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survey and overview of research on cyclic nucleotides 
in the nervous ystem'. There are three sections in 
this book: 
1. The formation, degradation and action of cyclic 
nucleotides; 
2. Their accumulation i cell systems under various 
conditions; 
3. Their functional role. 
The section on the metabolism of the nucleotides i a 
good survey of the enzymology of the cyclases and 
phosphodiesterases and their distribution in brain 
tissue with a useful account of the protein kinases. 
Those with an interest in factors and agents control- 
ling synthesis and breakdown of the nucleotides will 
find the chapter on the accumulation of cyclic 
nucleotides in intact cell systems under various 
conditions more relevant. Perhaps even more useful 
is the author's urvey of the possible role of cyclic 
nucleotides in the function of nervous tissue particu- 
larly when specific cell systems are involved. 
Particularly interesting are the observations that 
certain neurotransmitters which raise levels of cyclic 
AMP or cyclic GMP in the nervous ystem affect 
the firing rate of neurones, e.g., noradrenaline raises 
cyclic AMP in cerebellar Purkinje cells and modulates 
their electrical activity. Of possible greater significance 
for therpeutics are observations that the potency of 
certain anti-schizophrenic drugs is proportional to 
their capacity to inhibit a dopamine-sensitive adenyl- 
chyclase in the brain. More clearly understandable 
are the roles of cyclic AMP and cyclic GMP in mode- 
rating the fast excitatory postsynaptic potential gene- 
rated in the post-ganglionic fibre of the mammlian 
superior cervical ganglion. Such findings suggest that 
research on cyclic nucleotides in the nervous ystem 
will continue to reward the diligent, among whom 
must be included Dr. Daly himself. 
Except for a few instances (e.g., pp. 55-56) the 
text rarely degenerates into a list of references, and 
it is perhaps unrealistic to expect a prognosis longer 
than is provided. The reference list (15% of the 
volume) is very comprehensive; there is a useful 
appendix showing the structures of the nucleotides 
and agonists and antagonists utilised for their study, 
and the index is above average in its detail. 
G. B. Ansell 
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This is the second volume in a series which 'aims 
to keep the reader more easily informed on the many 
and varied developments in drug metabolism studies'. 
Like its predecessor, it contains review articles of high 
quality which cover a wider range of topics than 
might be expected from the title. Consenquently the 
volume will be of value as a source of reference to 
pharmacologists, toxicologists and biochemists 
interested in the broader aspects of the study of 
the biological fate of drugs and xenobiotics, and 
in the newer techniques available for drug meta- 
bolism studies. By today's tandards, I suppose 
the price of £13.50 is not excessive, and so 
this series should find a ready place in the library 
among the burgeoning ranks of review volumes. One 
caveat, however: although the book is excellently 
produced, with admirably clear layout and good 
diagrams and graphs, and plenty of them, this has 
meant a long delay before publication, such that the 
most recent advances are not included. Most of the 
articles cover work up to early 1975. 
In my view, the centre-piece of this collection is 
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the detailed survey of 'Newer aspects of glucuroni- 
dation' by Dutton and Burchell. With over 550 
citations, and an addendum dealing with work 
that appeared from 1974 up to late 1975, this 
well-written article covers the properties of UDP- 
glucuronyltransferase ndfactors affecting lucuroni- 
dation, as well as offering brief comments on the 
reaction mechanism. A number of contentious i sues 
in this field (enzyme compartmentation, solubili- 
sation, activation, heterogeneity) are dealt with 
lucidly and critically, giving ample references for 
further study. 
Fry and Bridges discuss the use in drug metabolism 
studies of cell suspensions, particularly of hepato- 
cytes isolated by collagen digestion, and of several 
cultured cell lines. These simplified in vitro systems 
have already furnished valuable insights into 
mechanisms and pathways of metabolism, and will 
be of enormous value in the future. The authors go to 
some length to point out the disadvantages of
conventional cell homogenate chniques for in vitro 
drug metabolism studies, and set out the pros and 
cons of the newer methods using whole cells. Apart 
from the introductory section, which is a rather 
superficial and poorly written summary of possible 
sites and mechanisms of action of xenobiotic hemi- 
cals, this chapter is clearly and logically set out. On a 
lighter note, I would quibble (pace, authors!) with 
the use on a couple of occasions of the now trendy 
word 'obfuscating' where 'complicating' or 'obscuring' 
is required. 
Pelkonen reviews 'Transplacental transfer of 
foreign compounds and their metabolism by the 
foetus' and with a number of comprehensive tables 
summarises factors affecting placental drug transport 
and drug metabolism in the human placenta nd 
foetal iver and adrenal, with emphasis on hydroxyla- 
tions of steroids and polycyclic aromatic hydro- 
carbons. This excellent review focuses on some 
important species differences in timing of the 
acquisition of drug metabolising capacities, and in 
his appraisal of the significance of these enzymes 
the author stresses the conclusion (which is perhaps 
surprising) that metabolism of xenobiotics in the 
foeto-placental unit occurs principally in foetal 
tissues and not in the placenta. 
Stable isotopes of hydrogen, carbon, nitrogen, 
and oxygen are nowadays reasonably cheap, and 
have many applications in drug metabolism studies 
as described by Hawkins. While they will never 
supplant radioactive isotopes for use as tracers 
because they require xpensive and laborious methods 
such as nuclear magnetic resonance and mass pectros- 
copy for detection, stable isotopes have unique 
properties which make them suitable for structural 
analysis of metabolites. After selective positional 
substitution of a heavy isotope into a drug molecule, 
combined gas chromatography/mass spectroscopy 
provides an exceptionally powerful tool for probing 
reaction mechanisms and for separating and deter- 
mining chemical structure of closely related metabo- 
lites present in small amounts. This is well illustrated 
by the numerous detailed examples given in this 
article. The use of selective ion-monitoring methods 
for the quantitative measurement i  biological fluids 
of drugs and metabolites i  also explained in depth. 
In Chapter 5, Schill et al. describe their extensive 
studies on ion-pair extraction methods which, 
althought elegant, are still relatively unfamiliar outside 
Scandinavia. Certain charged substances can be 
extracted from aqueous into organics phases with 
extraordinary efficiency as an uncharged 'ion-pair' 
after addition of an appropriate counter-ion. With 
certain tricks and after a good deal of trial and error, 
the method can be made specific for the extraction of 
particular substances, e.g., of drugs or metabolites 
from urine, thus forming the basis for a quantitative 
method of drug estimation. However, in view of the 
fact so much work is required for the development of
the extraction method for each substance, it seems to 
me that this approach is only likely to be justified 
where other simpler and more familiar methods 
cannot be used. 
The final chapter, by Mattock et al., concerns drug 
absorption and presents the comparisons afforded by 
in vivo studies of bio-availability and in vitro measure- 
ments of dissolution for 23 important drugs. The 
conclusion is that bio-availability, i.e., the percentage 
of an orally administered rug that enters the 
systemic irculation in unchanged form, tends to 
decrease as the time required for tablet dissolution 
increases, but that the predictive value of the simple 
dissolution tests is doubtful. The reviewers also 
discuss the concepts and methods used in bio- 
availability and dissolution studies. 
J. R. S. Hoult 
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